Lactated Ringer's and Dextrose 5% vs Only Lactated Ringer's in Labor
Part of paid clinical trials in Norfolk, Virginia.
- Sponsor
- Eastern Virginia Medical School
- Study ID
- NCT07124130
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- Induced Labor
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- 5% Dextrose (D5) in Normal Saline (NS) — DRUGA solution of 5% dextrose and lactate ringer will be given to one group of participants.
- Lactate Ringer — DRUGA Lactate Ringer solution will be given to one group of participants.
Study Details
The goal of this clinical trial is to determine which of two types of standard intravenous (IV) fluids (a combination of 5% dextrose and Lactated Ringers solution and Lactated Ringers solution alone) has a better influence on labor when inducing labor in pregnant women. The main questions it aims to answer are: 1. Does the use of 5% dextrose and Lactated Ringers lead to a shorter labor than the use of just Lactated Ringers? 2. Does the use of 5% dextrose and Lactated Ringers increase the risk of neonatal hypoglycemia when compared to Lactated Ringers? Participants in this trial will be randomly assigned to one of two groups: a group that receives a solution of 5% dextrose and Lactated Ringers, and a group that receives Lactated Ringers alone. Researchers will compare the outcomes of the two groups to see which IV fluid is more effective.
Key Dates
- Start date
- Sep 30, 2025
- Status verified
- Aug 2025
- Primary completion
- Mar 31, 2026
- Completion
- Mar 31, 2026
Study Design
- Enrollment
- 158 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: 5% dextrose and Lactate RingerParticipants randomized to this arm will receive an intravenous solution of 5% dextrose and Lactate Ringer during labor.
- Active Comparator: Lactate Ringer onlyParticipants randomized to this arm will receive an intravenous Lactate Ringer solution only.
Primary Outcome Measure
Time from Induction Start To Delivery [ Time Frame: From enrollment to the end of labor ]
Central Contacts
- Tetsuya Kawakita, MD757-446-7900
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Sentara Norfolk General Hospital | Norfolk | Virginia | 23507 |